EQL Pharma Investor Relations

Carl Lindgren

Chief Business Development Officer


B.Sc., Business Administration and Economics, Lund University




50,000 shares and 100,000 call options

Professional experience

Carl Lindgren has more than 25 years of experience from the Life Science industry within multinational companies like AstraZeneca PLC, Lundbeck A/S and Karo Pharma AB. He most recently joined from a position as VP M&A/Business Development within the executive management team of Karo Healthcare AB. Carl is furthermore Member of the Board of Iconovo AB and Biomedica Norden AB.